A single-center, retrospective record review of malignancy prevalence in patients with dermatomyositis with anti-transcription intermediary factor 1γ antibodies via line immunoassay versus immunoprecipitation

J Am Acad Dermatol. 2021 Feb;84(2):559-561. doi: 10.1016/j.jaad.2020.06.088. Epub 2020 Jun 30.

Authors

Skylar Westerdahl¹, Christopher M Hull², Jennie T Clarke², Christopher B Hansen², Jamie L W Rhoads³

Affiliations

¹ School of Medicine, University of Utah, Salt Lake City, Utah.
² Department of Dermatology, University of Utah, Salt Lake City, Utah.
³ Department of Dermatology, University of Utah, Salt Lake City, Utah. Electronic address: jamie.rhoads@hsc.utah.edu.

PMID: 32619611
DOI: 10.1016/j.jaad.2020.06.088

No abstract available

Publication types

Comparative Study
Letter

MeSH terms

Adolescent
Adult
Aged
Autoantibodies / blood*
Autoantibodies / immunology
Autoantibodies / isolation & purification
Dermatomyositis / blood
Dermatomyositis / complications*
Dermatomyositis / immunology
Female
Humans
Immunoassay / methods
Immunoassay / statistics & numerical data
Immunoprecipitation / statistics & numerical data
Male
Middle Aged
Neoplasms / blood
Neoplasms / diagnosis
Neoplasms / epidemiology*
Neoplasms / immunology
Prevalence
Retrospective Studies
Transcription Factors / immunology*
Young Adult

Substances

Autoantibodies
TRIM33 protein, human
Transcription Factors